参考文献/References:
[1] 李刚,许波,梁学振,等.基于网络药理学研究淫羊藿抗骨质疏松的分子机制[J].中国药理学通报,2018,34(2):267-273.
[2] HUBERT W,KRZYSZTOF D,ANNA B,et al.The RANKL/RANK/OPG signal trail:significance of genetic polymorphisms in the etiology of postmenopausal osteoporosis.[J].Ginekologia polska,2016,87(5):347-352.
[3] 杨莹,赵谦,李健.OPG/RANKL/RANK系统及其在口腔颌面部骨破坏疾病中的研究进展[J].临床口腔医学杂志,2018,34(6):378-380.
[4] SIAR C H,TSUJIGIWA H,ISHAK I,et al.RANK,RANKL,and OPG in recurrent solid/multicystic ameloblastoma:their distribution patterns and biologic significance[J].Oral Surgery,Oral Medicine,Oral Pathology and Oral Radiology,2015,119(1):83-91.
[5] JING S,BAO S,WEI W,et al.Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats[J].Journal of Molecular Histology,2016,47(4):389-399.
[6] SIGL V,PENNINGER J M.RANK and RANKL of bones,T cells,and the mammary glands[M].in:Osteoimmunology,2016:121-142.
[7] HYUN J K,SOHN E H,KIM Y J,et al.Effect of the combinatory mixture of rubus coreanus miquel and astragalus membranaceus bunge extracts on ovariectomy-induced osteoporosis in mice and anti-RANK signaling effect[J].Journal of Ethnopharmacology,2014(2):951-959.
[8] SUN J,SUN B,WANG W,et al.Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats[J].Journal of Molecular Histology,2016,47(4):389-399.
[9] XIONG M Y,LIU L Q,LIU S Q,et al.Effects of osteoprotegerin,RANK and RANKL on bone destruction and collapse in avascular necrosis femoral head[J].American Journal of Translational Research,2016,8(7):3133-3140.
[10] BENASCIUTTI E,MARIANI E,OLIVA L,et al.MHC class Ⅱ transactivator is an in vivo regulator of osteoclast differentiation and bone homeostasis co-opted from adaptive immunity[J].Journal of Bone and Mineral Research,2014,29(2):290-303.
[11] 查小云,胡予.骨质疏松相关信号通路研究进展[J].中国骨质疏松杂志,2014,20(2):205-209.
[12] GAO L,ZHANG L,QI H,et al.Middle-aged female depression in perimenopausal period and square dance intervention[J].Psychiatria Danubina,2016,28(4):372-378.
[13] 王俊玲,黄思敏,梁启瑶,等.雌激素的来源及其在骨代谢中的作用[J].中国骨质疏松杂志,2015,21(6):729-732.
[14] KUANG W,ZHENG L,XU X,et al.Dysregulation of the miR-146a-Smad4 axis impairs osteogenesis of bone mesenchymal stem cells under inflammation[J].Bone Research,2017,5(4):375-383.
[15] 张韬,陈冬冬,翁艳,等.Sema4D基因沉默对骨髓间充质干细胞成骨及成脂肪分化相关基因表达的影响[J].厦门大学学报:自然科学版,2017,56(2):173-177.
[16] 李喆,曹寅生.OPG/RANKL/RANK系统与骨质疏松症关系的研究进展[J].湖南中医杂志,2018,34(8):229-232.
[17] 王忠,陈寅萤,张盈颖,等.多组分多靶点中药药理作用机制研究中的问题和解决策略[J].中国实验方剂学杂志,2018,24(5):1-6.
[18] 何丹丹,夏海建,蒋俊,等.淫羊藿素与RANKL蛋白靶点结合抑制破骨细胞分化抗骨质疏松作用研究[J].中草药,2017,48(22):4707-4712.
[19] 宋敏,罗晓,李宁,等.淫羊藿总黄酮含药血清对成骨细胞OPG/OPGL基因表达的影响[J].时珍国医国药,2012,23(4):883-886.
[20] 胡倩影,尹瑞林,王一飞,等.杜仲中松脂素二葡萄糖苷和松脂素对成骨细胞中OPG和RANKL表达的影响[J].中国实验方剂学杂志,2018,24(10):181-186.
[21] 兰波,刘亭,谢玉敏,等.两种杜仲黄酮类化合物对成骨细胞OPG/RANKL及成骨相关转录因子的影响[J].中国实验方剂学杂志,2014,20(22):180-184.
[22] 朱振标,林之斌,丁晓莉,等.骨碎补总黄酮对去卵巢大鼠RANKL/OPG平衡及MAPK信号通路的影响[J].海南医学,2015,26(9):1249-1253.
[23] 刘康,吴风晴,吴连国,等.骨碎补总黄酮对骨质疏松模型大鼠OPG/RANKL/RANK轴系统的影响[J].中国现代应用药学,2015,32(6):652-656.
[24] 郑德开,阮诗钒,叶春华,等.巴戟天对卵巢切除大鼠OPG、RANKL蛋白表达的影响[J].江西中医药大学学报,2018,30(3):74-76.
[25] 王青华.巴戟天与雌激素对骨质疏松大鼠破骨细胞RANK和CAII的表达影响分析[J].中华中医药学刊,2015,33(5):1224-1226.
[26] 黄慧,陈健,何剑全,等.巴戟天含药血清对成骨-破骨细胞共育体系OPGmRNA、RANKLmRNA表达的影响[J].中国骨质疏松杂志,2015,21(1):67-71.
[27] 黄媛,徐艳,易学良,等.川续断皂苷Ⅵ通过JNK信号通路促进骨髓间充质干细胞成骨分化[J].广州中医药大学学报,2018,35(5):887-893.
[28] 赵永见,唐德志,程少丹,等.不同剂量蛇床子素对OPG基因敲除小鼠和去卵巢骨质疏松大鼠作用疗效的比较研究[J].中国骨质疏松杂志,2015,21(2):147-151.
[29] 袁斯远,何芳,孔蓓蓓,等.葛根素对破骨细胞形成以及成骨细胞OPG/RANKL mRNA表达的影响[J].中华中医药杂志,2015,30(11):3889-3892.
[30] 祁琳,张鹏,屈野,等.LC调节人成骨样MG-63细胞表达OPG、RANKL分子机制的研究[J].中国骨质疏松杂志,2013,19(2):125-130.